Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence

Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive loss of dopaminergic neurons, appearance of Lewy bodies and presence of neuroinflammation. No treatments currently exist to prevent PD or delay its progression, and dopaminergic substitution treatments just rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Storelli, Elisa, Cassina, Niccolò, Rasini, Emanuela, Marino, Franca, Cosentino, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353825/
https://www.ncbi.nlm.nih.gov/pubmed/30733703
http://dx.doi.org/10.3389/fneur.2019.00013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353825/
https://www.ncbi.nlm.nih.gov/pubmed/30733703
http://dx.doi.org/10.3389/fneur.2019.00013

Ejemplares similares